Patritumab deruxtecan, CAS [[2227102-46-5]]

Product Overview

• Article Name: Patritumab deruxtecan, CAS [[2227102-46-5]]
• Biozol Catalog Number: MCE-HY-P99813
• Supplier Catalog Number: HY-P99813
• Alternative Catalog Number: MCE-HY-P99813-1MG,MCE-HY-P99813-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: HER3-DXd, U3-1402

Product Description

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity[1].

Product Properties

• Molecular Weight: 155238 (average)
• Purity: 99.08
• CAS Number: [2227102-46-5]
• Target: Antibody-Drug Conjugates (ADCs)

Application Notes

• Application Notes: ADC Related